Roche's Accu-Chek Combo system has been cleared by the US Food and Drug Administration (FDA) for insulin pump therapy.
The Accu-Chek Combo system features an insulin cartridge that can hold up to 315 units of insulin, as well as a full-color display that provides blood glucose data, insulin dose information and pump settings.
The system combines a blood glucose meter with an insulin pump, which enables two-way wireless communication via bluetooth wireless technology.
The metee, which features a bolus advice function, allows users to operate the insulin pump remotely, easily calculate and deliver a right amount of insulin bolus without touching the pump.
Roche Diabetes Care head Luc Vierstraete said, "This new system is designed to support insulin pump patients in managing diabetes easily and discreetly in their everyday life."
Roche Diagnostics COO Daniel O’ Day said the company’s new insulin pump system will soon be available for people with diabetes in the US.
"With this clearance we are now looking forward to launch the second device in the U.S. this year, after the successful clearance of the Accu-Chek Nano SmartView system in the first quarter," Day added.
"Both launches represent a significant milestone for our Diabetes Care business."